CTCBIO Inc. (KOSDAQ:060590)
South Korea · Delayed Price · Currency is KRW 6,670.00
+40.00 (0.60%)
At close: Jul 18, 2025, 3:30 PM KST
CTCBIO Revenue
CTCBIO had revenue of 34.10B KRW in the quarter ending March 31, 2025, with 2.72% growth. This brings the company's revenue in the last twelve months to 145.31B, up 6.98% year-over-year. In the year 2024, CTCBIO had annual revenue of 144.41B with 4.74% growth.
Revenue (ttm)
145.31B
Revenue Growth
+6.98%
P/S Ratio
1.10
Revenue / Employee
593.11M
Employees
245
Market Cap
159.47B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 144.41B | 6.53B | 4.74% |
| Dec 31, 2023 | 137.88B | -27.33B | -16.54% |
| Dec 31, 2022 | 165.21B | 24.89B | 17.74% |
| Dec 31, 2021 | 140.32B | 10.29B | 7.91% |
| Dec 31, 2020 | 130.03B | -6.09B | -4.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| Hanwha Aerospace | 15.28T |
| Doosan Enerbility | 15.88T |
| KB Financial Group | 14.93T |